Magnetic Resonance Imaging–Based Artificial Intelligence in Predicting Prostate Cancer Biochemical Recurrence: Systematic Review and Meta-Analysis - Takeaways - MDSpire

Magnetic Resonance Imaging–Based Artificial Intelligence in Predicting Prostate Cancer Biochemical Recurrence: Systematic Review and Meta-Analysis

  • By

  • Yanjun Jin

  • Tianzuo Yuan

  • Zhiyuan Chen

  • July 7, 2026

  • 0 min

Share

  • 1

    Prostate cancer is a leading malignancy among men, with an expected 313,780 new cases and 35,770 deaths in the U.S. in 2025.

  • 2

    Biochemical recurrence (BCR) after treatment significantly worsens prognosis, increasing risks of metastasis and mortality.

  • 3

    Current detection methods for prostate cancer, including PSA testing and MRI, have limitations in specificity and reliability.

  • 4

    Artificial intelligence (AI) has shown potential in improving predictive accuracy for BCR using MRI-based models.

  • 5

    Despite promising results, current AI studies are limited by small sample sizes and lack of multicenter validation.

Original Source(s)

Magnetic Resonance Imaging–Based Artificial Intelligence in Predicting Prostate Cancer Biochemical Recurrence: Systematic Review and Meta-Analysis

  • by Yanjun Jin, Tianzuo Yuan, Zhiyuan Chen

  • July 7, 2026

Related Content

Regression of retinal capillary hemangioblastoma with systemic belzutifan in von Hippel–Lindau disease: a case report

Long-term outcomes of definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for postoperative locoregional recurrent esophageal cancer: a prospective phase II study

Higher Framingham steatosis index is associated with prevalent breast cancer in women: cross-sectional evidence from NHANES 1999–2018 and an exploratory hospital-based dataset